This High-Yield ETF Has Increased Payouts 13 Years Straight -- and It's Still Undervalued

Schwab U.S. Dividend Equity ETF (SCHD), launched October 2011, has increased its total annual dividend every year since inception (2024 DPS $0.9944) and through 3Q2025 has paid $0.7694; a Q4 payout ≥ $0.23 would extend the streak to 14 years. The fund requires candidate stocks to have 10 consecutive years of dividend payments and screens on ROE, cash-flow-to-debt, dividend yield and five-year dividend growth to build a market-cap-weighted 100-stock portfolio; top sectors (Dec. 1) are energy 19.3%, consumer staples 18.5%, healthcare 16.1%, industrials 12.3% and financials 9.4%, with top holdings including Merck, Amgen, Cisco, AbbVie and Coca-Cola. SCHD offers a 3.8% yield, 0.06% expense ratio and a P/E of 16.7 versus the S&P 500's 25, implying a value/defensive tilt and potential downside protection for income-focused portfolios.

Analysis

Market structure: Dividend-focused ETFs like SCHD are beneficiaries of a multi-year shift into yield and quality — big-cap cash generators (KO, ABBV, AMGN, CSCO, MRK) gain structural bid while high-P/E growth names (QQQ-heavy) lose relative flows. SCHD’s 3.8% yield and P/E 16.7 vs S&P 25 create a downside-buffer trade: in a 10-20% equity drawdown bulls in income rotate to high-yield defensives, increasing relative demand and compressing spreads in those sectors. Cross-asset: a move lower in 10y yields (100–150bp from current levels) would amplify SCHD flows; a sustained rise above 4.5% reverses the trade and favors short-duration growth — energy exposure (19%) links SCHD performance to oil moves and commodity volatility.

Risk assessment: Key tail risk is simultaneous dividend cuts across cyclical constituents in a deep recession — a >20% EPS shock to energy/industrials could force payouts lower and break the streak. Immediate (days): watch late-December Q4 distribution threshold ($0.23) to maintain the 14-year streak; short-term (weeks/months): year-end rebalancing could drive 1–3% intraday flows; long-term: structural rate shifts or regulatory action in pharma/healthcare (drug pricing) can shave FCF by 10–30%. Hidden dependency: SCHD’s market-cap weighting concentrates idiosyncratic risk; energy concentration exposes income profile to oil < $70/bbl scenarios. Catalysts: Q4 dividends, 10y Treasury prints, oil inventory shocks, and big buyback announcements.

Trade implications: Direct play — establish a 2–4% portfolio long in SCHD now, scale to 4–6% if yield rises above 4.2% or Q4 dividend confirms >= $0.23 (12-month target total return 6–8%). Pair trade — go dollar-neutral long equal-weight KO/ABBV/AMGN (tickers) vs short QQQ for 3–6 months to capture defensive spread; initial size 1–2% net capital. Options — sell 90-day covered calls on SCHD at ~5% OTM to harvest premium while holding dividend exposure; buy 3-month put protection on SCHD if 10y >4.5% or oil < $70 triggers (protects downside >6–8%).

Contrarian angles: Consensus treats SCHD as ‘safe’ income but underprices concentration and rate-sensitivity — a rapid 50–75bp upward shock in yields could compress NAV by 5–10% and remove yield cushion. The market may be underestimating energy cyclicality: if Brent falls below $70 for >60 days, SCHD’s YTD yield could drop 30–40bp and force reallocations. Historical parallels (2014–2016 value cycles) show dividend ETFs outperform in mild recessions but underperform when growth re-accelerates; therefore size positions to be tactical (2–6% bands) not permanent core.

Key Decisions for Investors

• Establish a 2–4% portfolio long position in SCHD immediately; scale up to 4–6% only if SCHD’s trailing yield rises above 4.2% or the Q4 dividend announced in late December is >= $0.23 (this preserves the streak and signals payout stability).
• Implement a dollar-neutral pair trade: long equal-dollar KO + ABBV + AMGN (total 1–2% portfolio exposure) vs short an equal dollar amount of QQQ for 3–6 months to capture defensive outperformance; trim/close if QQQ outperforms by >8% in a month or if 10y falls >50bp.
• Write 90-day covered calls on SCHD at ~5% OTM and roll monthly to boost income; concurrently buy a 3-month SCHD put (or put spread) sized to cover 50% of the position if 10y Treasury >4.5% or Brent < $70 (risk triggers).
• Trim 5–10% exposure to high-P/E growth (NVDA/NFLX concentrated positions) and redeploy into SCHD or the KO/ABBV/AMGN basket if SCHD yield holds >3.9% post-Q4 announcements; if SCHD Q4 < $0.23, reduce SCHD allocation by 50% within 3 trading days.